Dixit Sanjay, Gerstenfeld Edward P, Ratcliffe Sarah J, Cooper Joshua M, Russo Andrea M, Kimmel Stephen E, Callans David J, Lin David, Verdino Ralph J, Patel Vickas V, Zado Erica, Marchlinski Francis E
Cardiovascular Division, Hospital of The University of Pennsylvania and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Heart Rhythm. 2008 Feb;5(2):174-81. doi: 10.1016/j.hrthm.2007.09.024. Epub 2007 Oct 2.
Current atrial fibrillation (AF) ablation involves isolation of all pulmonary veins (PVs) with or without additional linear lesions. However, whether such extensive ablation is necessary is unclear.
The purpose of this study was to assess the efficacy of different ablation strategies on long-term AF control.
We prospectively randomized patients to undergo isolation of all versus arrhythmogenic PVs (identified by standardized stimulation protocol). PV isolation was guided by circular mapping catheter. The endpoint was entry/exit block persisting for > or = 20 minutes. Patients were evaluated at three clinic visits (at 6 weeks, 6 months, and 1 year) and multiple transtelephonic monitoring periods. Antiarrhythmic drugs were discontinued at 6 weeks. Primary study endpoint was long-term AF control (freedom or >90% reduction in AF burden off or on previously ineffective antiarrhythmic drugs at 1 year after a single ablation procedure).
Over a 20-month period, 105 patients (76 men and 29 women, age 57 +/- 9 years; paroxysmal AF = 77) were randomized, and 103 patients completed 1-year follow-up (51 patients in all-PV arm, 52 patients in arrhythmogenic PV arm). The primary endpoint was achieved in 75 (73%) patients and was similar in patients randomized to all-PV arm versus arrhythmogenic PV arm [38 (75%) patients vs 37 (71%) patients, respectively; odds ratio 1.18, 95% confidence interval 0.50, 2.83, P = .70]. Secondary study endpoints, including freedom from AF off antiarrhythmic drugs, total procedure/fluoroscopy times, and occurrence of serious adverse events, were not different between the two groups.
In a randomized comparison, isolation of arrhythmogenic veins was as efficacious as empiric isolation of all veins in achieving long-term AF control.
目前的心房颤动(房颤)消融术包括隔离所有肺静脉(PVs),可伴有或不伴有额外的线性损伤。然而,这种广泛消融是否必要尚不清楚。
本研究旨在评估不同消融策略对长期房颤控制的疗效。
我们前瞻性地将患者随机分为接受所有PVs隔离组和致心律失常PVs(通过标准化刺激方案确定)隔离组。PV隔离由环状标测导管引导。终点是入口/出口阻滞持续≥20分钟。在三次门诊就诊(6周、6个月和1年)以及多个经电话监测期对患者进行评估。6周时停用抗心律失常药物。主要研究终点是长期房颤控制(单次消融术后1年,在停用或继续使用先前无效的抗心律失常药物的情况下,房颤负荷自由或降低>90%)。
在20个月的时间里,105例患者(76例男性和29例女性,年龄57±9岁;阵发性房颤=77例)被随机分组,103例患者完成了1年随访(全PV组51例患者,致心律失常PV组52例患者)。75例(73%)患者达到主要终点,随机分组至全PV组与致心律失常PV组的患者相似[分别为38例(75%)患者和37例(71%)患者;优势比1.18,95%置信区间0.50,2.83,P = 0.70]。两组的次要研究终点,包括停用抗心律失常药物后的房颤自由、总手术/透视时间以及严重不良事件的发生情况,均无差异。
在随机对照比较中,隔离致心律失常静脉在实现长期房颤控制方面与经验性隔离所有静脉同样有效。